Updated on 16 September 2026
Revolutionary Youngflex Preventive Therapy for chronic pains
Founder & CEO at Youngflex Manufacturing Inc.
Canada
About
Based on huge market demand from many chronic pain patients, who like a safe & effective treatment method for their chronic pain symptoms, we started our research project in mid 1990's. After having completed more than 50,000 cases of clinical trials, we successfully invented our revolutionary Youngflex Preventive Therapy with an inventive copyright issued by Canadian CIPO stipulating brand new SOP operating procedures and Tianjin Chinese Medicine Hospital effective clinical testing report. Recently, after our two-year market simulation testing period in China, we have built up many successful cases including but not limited to a fibromyalgia case from a patient, who constantly work under pressure & fatigue. She had to sit on wheelchair and class A hospital did not have service to help her recover. But after a number of treatments incorporating Youngflex Therapy, she was able to recover. She can now work and live without a wheelchair. We are now in the stage of angel investment looking for investors with high profile volume members from large & medium technological companies to be our Youngflex Preventive Centers' members as our initial niche market segment clienteles. We plan to set up two Youngflex Preventive Centers in GBA to build up our model and expand to other major cities in China. We plan to give out 10% of our shareholding for RMB5 million to set up two Youngflex Preventive Centers as model shops. Estimated total sales after three years would be RMB65 million with NPAT 35%+ about RMB26 million. Since there are already over 300 million chronic pain patients in China, we intially only tackle 1%+ about 4 million clients. From our market simulation records, these high profile members from large & medium technological companies in China have high IQ, good net worth & care for health. They prefer well proven natural treatment method for their chronic pain subhealth problems to keep up work efficiency due to constant pressure & fatigue. We plan to complete three phases of business expansion, finally to roll out fully automatic robotic AI centers with big data operations system to cope with fast climbing business growth pattern. Interested reputable investors with volume elite clientele base, please email to yongflex@163.com for Youngflex ppt or whchat: bc1683yt.
Type
- Private Equity & Venture Capital
Applies to
- Mainland China
Organisation
Similar opportunities
Project
Revolutionary Youngflex Preventive Therapy for chronic pains
- No
- Yes
- Equity
- Bio-Tech
- Technology
- IP Related
- Private Project
- Equity (private)
- Big Data Solution
- Marketing Technology
- Professional Services
- Minority Shareholdings
- 500,001 to 1,000,000 USD
- 5,000,001 to 7,500,000 USD
- Private Equity & Venture Capital
- Investment / Financing Discussion
- Telecommunication & Wireless Networking
Barry Chan
Founder & CEO at Youngflex Manufacturing Inc.
Canada
Project
- No
- Yes
- Equity
- Technology
- Private Project
- Private Banking
- Health Technology
- Equity (private)
- Medical Technology
- Financial Services
- Investment Banking
- Mergers & Acquisition
- Direct Equity Investment
- 2,500,001 to 5,000,000 USD
- 7,500,001 to 10,000,000 USD
- Private Equity & Venture Capital
- Investment / Financing Discussion
Avi Lior
CEO at Therapnea Labs PLC
Cyprus
Service
Medical care in China, made clear. Holistic China Medical Solution
- E-commerce
- Central Asia
- North America
- Mainland China
- South-East Asia
- Industry Solutions
- Enterprise Solutions
- Professional Services
- Latin America & Caribbean
Yuanren Pan
Overseas strategy head at Hengyu Health Management Consulting
China (Hong Kong)